U.S. Preventive Services Task Force at a Crossroads: Signals of Restart, Risks of Redirection
Experts and former U.S. Preventive Services Task Force (USPSTF) chairs Alex Krist and Michael Barry reflect on recent developments at the Task Force, which signal disruption and potential renewal.
Over the past year, the Task Force’s last three scheduled meetings were abruptly cancelled. These sessions are essential for confirming and voting on new recommendations. In 2025, the USPSTF issued only five new recommendations, far below its typical output of 20 or more annually. No new recommendations have been released in 2026. This slowdown is not due to lack of effort. Task Force members continue to meet weekly, advancing evidence reviews and preparing recommendations, but without formal meetings, their latest guidance will never reach clinicians and patients.
Against this backdrop, a newly released Federal Register notice requesting nominations for USPSTF membership introduces a notable shift. On its face, the notice is a positive signal. It suggests that the administration intends to restart the Task Force’s operations and resume its core function of issuing evidence-based recommendations. After a year of stalled output, this is an important step forward.
However, the content of the notice raises substantive concerns about the future direction and composition of the Task Force. Historically, the USPSTF has been composed solely of primary care clinicians. This discipline is the expert of prevention, and preventive interventions are implemented almost entirely in primary care. The current notice explicitly encourages nominations from a wide range of physician specialties such as anesthesiology, cardiology, oncology, radiology, nephrology, and surgery. While topical expertise can be valuable, this risks altering the fundamental orientation of the Task Force.
The distinction matters. Preventive services are delivered to individuals who are, by definition, asymptomatic. This requires a particularly rigorous application of the principle of “first, do no harm.” Any adverse effect from screening, follow-up procedures, or preventive medications can harm otherwise healthy people. Primary care clinicians are specifically trained to weigh these tradeoffs across populations, balancing small potential benefits against real risks of overdiagnosis, overtreatment, and downstream complications. Specialists, by contrast, are typically trained in the diagnosis and treatment of established disease. Their clinical lens is often focused on the severity and management of specific conditions, which can lead to different thresholds for action. Over 40 years, the Task Force has built trust in the primary care community both through their perspective as practicing primary care clinicians and their stringent avoidance of conflicts of interest.
Second, prevention inherently requires a whole-person perspective. Although many USPSTF recommendations address specific diseases, such as cancer screening or cardiovascular risk reduction, their application must consider the broader health context of the whole person. Primary care clinicians are trained to integrate multiple risks, comorbidities, and patient preferences across the lifespan. Specialists are more likely to focus on single organ systems or disease processes. A Task Force dominated by specialty perspectives risks fragmenting what has historically been a whole-person approach to prevention. Third, the potential for bias and conflicts of interest is higher when recommendations intersect closely with specialty practice. Specialists may, often unintentionally, perceive conditions within their field as more prevalent or severe, or may favor interventions aligned with their training and clinical experience. The USPSTF and other guideline bodies have published policies to transparently show how they work to limit these biases.
The Task Force is not a policymaking or cost-containment body, and when members deliberate, they are not focusing on making a decision about insurance coverage. Its role is to rigorously assess the evidence and help clinicians and patients know what works—and what doesn’t—when it comes to prevention. Under the Affordable Care Act in 2010, A and B recommendations were linked to mandatory coverage precisely because they reflect at least moderate certainty of a meaningful net benefit. This is a scientifically grounded threshold for making national coverage decisions. The trust in that linkage rests on the Task Force’s consideration of the evidence of benefits and harms of preventive interventions. If the Task Force begins to blend evidence assessment with coverage deliberations, it risks eroding that trust. Clinicians, policymakers, and the public will no longer be able to distinguish whether recommendations are driven by the science of benefit and harm or by downstream political considerations.
Finally, the operational demands of the USPSTF should not be underestimated. Volunteer members typically contribute to dozens of recommendations annually, requiring broad methodological expertise across diverse clinical topics. This breadth aligns more closely with generalist training in primary care than with the narrower scope of most specialties. Ensuring that future members can meet these demands will be essential to restoring the Task Force’s productivity. The Task Force curates more than 90 recommendations across the age spectrum. How would an anesthesiologist or radiologist contribute to deliberations about lipid screening in children, or preventing falls in the elderly? Specialists should be invited to contribute when a particular recommendation would benefit from their expertise, which is what the Task Force has traditionally done.
The Federal Register notice offers cautious optimism that the USPSTF will resume its work, but at the same time, it signals potential changes that could reshape the Task Force’s composition and mission. Preserving the USPSTF’s effectiveness will depend on maintaining its focus on rigorous evidence review, safeguarding its freedom from conflicts of interest, and ensuring that its membership reflects the expertise required to evaluate the broad spectrum of preventive care. The stakes are high. Trust in preventive recommendations and the health of every American who depends on them hangs in the balance.
Disclaimer: AcademyHealth has been leading the field in preserving the integrity of the Task Force, through the creation of multi-stakeholder coalitions, meetings and technical analysis with Congress, evidence support in the Courts, and providing background and context to national media outlets. This advocacy work did not influence this piece.
About the authors:
Alex Krist M.D. M.P.H., Former Member and Chair of the U.S. Preventive Services Task Force (2014-2021), Professor of Family Medicine and Population Health Virginia Commonwealth University
Michael Barry M.D., Former Member and Chair of the US Preventive Services Task Force (2017-2024), Professor of Medicine Harvard Medical School